Report Description

Global clinical trial outsourcing market is anticipated to register robust growth with a significant CAGR in the forecast period, 2023-2027.  Clinical trial outsourcing refers to the delegation of several duties involved in conducting clinical trials and related activities by the medical or pharmaceutical companies to indicate what works for the patient and what does not by testing them in a professional setup. The market growth can be attributed to the rising need for new and advanced drugs and therapeutics to be tested and approved to address the rising prevalence of several life-threatening diseases. Moreover, the increasing investments in healthcare research and drug development activities are also adding to the market growth. Outsourcing clinical trials offers several advantages to pharmaceutical and biotech companies such as cost efficiency, minimum timeline, timely result delivery, etc. As a result, pharmaceutical industries are increasingly opting for clinical trial outsourcing services to avail significant advantages in terms of cost as well as efficient drugs or vaccines. Apart from this, the growing patient population and rising prevalence of several lifestyle and cardiovascular diseases are resulting in an increased healthcare expenditure. Hence, the demand for advanced and effective treatments, which provide value-based solutions to patients is increasing. This eventually is adding to the growth of the global clinical outsourcing market in the forecast period.

Pharmaceutical companies are looking for ways to reduce overall expenses, for which they need to save costs in the research and development infrastructure and downsize their research staff. Therefore, pharma companies are outsourcing research and development work to a third party in order to increase the success rate, accelerate drug approvals and increase profits. Moreover, growing investments by both private players and government authorities for the development of novel drugs and therapies are providing a boost to the global clinical trial outsourcing market.

In addition, the development of precision medicines is gaining wide traction in the healthcare sector. Precision medicine is a customized healthcare model that has tailored treatments and practices according to a patient’s molecular profiling and genetics. Most of the clinical research outsourcing (CROs) providers are extensively working on developing precision medicine to reduce the overall cost of failure of a drug and develop effective therapy in less time. CROs provide guidance and support through all the stages of precision medicine trials. As a result, several biotech and pharma companies are highly relying on such service providers for drug trials and approvals, which in turn, is adding to the growth of the global clinical trial outsourcing market.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The global clinical trial outsourcing market is segmented on the basis of clinical trial phase, therapeutic area, end user, competitive landscape, and regional distribution. On the basis of clinical trial phase, the market is segmented into Phase 0, Phase 1, Phase 3, and Phase 4. Based on the therapeutic area, the market is fragmented into oncology, hematology, central nervous system, cardiovascular/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices, and others. By end user, the market is bifurcated between biotechnology & pharmaceutical companies, medical device companies, and academic & research institutions. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is anticipated to hold a considerable market share in the coming years due to the presence of large market players in the region.

Company Profile

ICON plc. (PRA Health Sciences), PAREXEL International Corp., Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.), Sygnature Discovery Limited, WuXi AppTec Co., Ltd., Laboratory Corporation of America Holdings, Jubilant Biosys Limited, Charles River Laboratories International, Inc., Albany Molecular Research, Inc., and Syneos Health Inc are the leading market players of the global clinical trial outsourcing market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Clinical Trial Phase

·         Therapeutic Area

·         End User

Regional scope

North America, Europe, Asia Pacific, Middle East and Africa, South America

Key companies profiled

ICON plc. (PRA Health Sciences), PAREXEL International Corp., Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.), Sygnature Discovery Limited, WuXi AppTec Co., Ltd., Laboratory Corporation of America Holdings, Jubilant Biosys Limited, Charles River Laboratories International, Inc., Albany Molecular Research, Inc., and Syneos Health Inc

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global Clinical Trial outsourcing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Clinical Trial Outsourcing Market, By Clinical Trial Phase:
    • Phase 0
    • Phase 1
    • Phase 2
    • Phase 3
    • Phase 4
  • Clinical Trial Outsourcing Market, By Therapeutic Area:
    • Oncology
    • Hematology
    • Central Nervous System
    • Cardiovascular/Metabolic
    • Respiratory
    • Infectious Diseases
    • Immunology
    • Rare Diseases
    • Medical Devices
    • Others
  • Clinical Trial Outsourcing Market, By End Users:
    • Biotechnology & Pharmaceutical Companies
    • Medical Device Companies
    • Academic & Research Institutions
  • Clinical Trial outsourcing Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o   Middle East and Africa

§  Saudi Arabia

§  South Africa

§  UAE

o   South America

§  Brazil

§  Argentina

§  Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trial Outsourcing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Clinical Trial Outsourcing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Clinical Trial Outsourcing Market

5.    Voice of Customer

5.1.  Reasons for Clinical Trial Outsourcing

5.2.  Clinical Trial Outsourcing, By Region

5.3.  Clinical Trial Outsourcing, By Clinical Trial Phase

5.4.  Clinical Trial Outsourcing, By Therapeutic Area

5.5.  Brand Awareness

6.    Global Clinical Trial Outsourcing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4)

6.2.2.     By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, Others)

6.2.3.     By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions)

6.2.4.     By Company (2021)

6.2.5.     By Region

6.3.  Product Market Map

7.    North America Clinical Trial Outsourcing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Clinical Trial Phase

7.2.2.     By Therapeutic Area

7.2.3.     By End User

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Clinical Trial Outsourcing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Clinical Trial Phase

7.3.1.2.2.             By Therapeutic Area

7.3.1.2.3.             By End User

7.3.2.     Mexico Clinical Trial Outsourcing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Clinical Trial Phase

7.3.2.2.2.             By Therapeutic Area

7.3.2.2.3.             By End User

7.3.3.     Canada Clinical Trial Outsourcing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Clinical Trial Phase

7.3.3.2.2.             By Therapeutic Area

7.3.3.2.3.             By End User

8.    Europe Clinical Trial Outsourcing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Clinical Trial Phase

8.2.2.     By Therapeutic Area

8.2.3.     By End User

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Clinical Trial Outsourcing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Clinical Trial Phase

8.3.1.2.2.             By Therapeutic Area

8.3.1.2.3.             By End User

8.3.2.     Germany Clinical Trial Outsourcing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Clinical Trial Phase

8.3.2.2.2.             By Therapeutic Area

8.3.2.2.3.             By End User

8.3.3.     United Kingdom Clinical Trial Outsourcing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Clinical Trial Phase

8.3.3.2.2.             By Therapeutic Area

8.3.3.2.3.             By End User

8.3.4.     Italy Clinical Trial Outsourcing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Clinical Trial Phase

8.3.4.2.2.             By Therapeutic Area

8.3.4.2.3.             By End User

8.3.5.     Spain Clinical Trial Outsourcing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Clinical Trial Phase

8.3.5.2.2.             By Therapeutic Area

8.3.5.2.3.             By End User

9.    Asia-Pacific Clinical Trial Outsourcing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Clinical Trial Phase

9.2.2.     By Therapeutic Area

9.2.3.     By End User

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Clinical Trial Outsourcing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Clinical Trial Phase

9.3.1.2.2.             By Therapeutic Area

9.3.1.2.3.             By End User

9.3.2.     India Clinical Trial Outsourcing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Clinical Trial Phase

9.3.2.2.2.             By Therapeutic Area

9.3.2.2.3.             By End User

9.3.3.     South Korea Clinical Trial Outsourcing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Clinical Trial Phase

9.3.3.2.2.             By Therapeutic Area

9.3.3.2.3.             By End User

9.3.4.     Japan Clinical Trial Outsourcing Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Clinical Trial Phase

9.3.4.2.2.             By Therapeutic Area

9.3.4.2.3.             By End User

9.3.5.     Australia Clinical Trial Outsourcing Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Clinical Trial Phase

9.3.5.2.2.             By Therapeutic Area

9.3.5.2.3.             By End User

10.  South America Clinical Trial Outsourcing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Clinical Trial Phase

10.2.2.  By Therapeutic Area

10.2.3.  By End User

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Clinical Trial Outsourcing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Clinical Trial Phase

10.3.1.2.2.           By Therapeutic Area

10.3.1.2.3.           By End User

10.3.2.  Argentina Clinical Trial Outsourcing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Clinical Trial Phase

10.3.2.2.2.           By Therapeutic Area

10.3.2.2.3.           By End User

10.3.3.  Colombia Clinical Trial Outsourcing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Clinical Trial Phase

10.3.3.2.2.           By Therapeutic Area

10.3.3.2.3.           By End User

11.  Middle East and Africa Clinical Trial Outsourcing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Clinical Trial Phase

11.2.2.  By Therapeutic Area

11.2.3.  By End User

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Clinical Trial Outsourcing Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Clinical Trial Phase

11.3.1.2.2.           By Therapeutic Area

11.3.1.2.3.           By End User

11.3.2.  Saudi Arabia Clinical Trial Outsourcing Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Clinical Trial Phase

11.3.2.2.2.           By Therapeutic Area

11.3.2.2.3.           By End User

11.3.3.  UAE Clinical Trial Outsourcing Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Clinical Trial Phase

11.3.3.2.2.           By Therapeutic Area

11.3.3.2.3.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              ICON plc. (PRA Health Sciences)

14.2.              PAREXEL International Corp.

14.3.              Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.)

14.4.              Sygnature Discovery Limited

14.5.              WuXi AppTec Co., Ltd.

14.6.              Laboratory Corporation of America Holdings

14.7.              Jubilant Biosys Limited

14.8.              Charles River Laboratories International, Inc.

14.9.              Albany Molecular Research, Inc.

14.10.            Syneos Health Inc

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The global clinical trial outsourcing market is primarily propelled by the rising need for the new and advanced drugs and therapeutics to be tested and approved to address the rising prevalence of several life-threatening diseases.

down-arrow

Based on the therapeutic area, the market is fragmented into oncology, hematology, central nervous system, cardiovascular/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices, and others. Among these, the oncology segment is anticipated to hold a prominent market share in the coming years. This is due to the high prevalence of cancer and the on-going drug trails to develop effective therapies and medicines for the condition.

down-arrow

ICON plc. (PRA Health Sciences), PAREXEL International Corp., Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.), Sygnature Discovery Limited, WuXi AppTec Co., Ltd., Laboratory Corporation of America Holdings, Jubilant Biosys Limited, Charles River Laboratories International, Inc., Albany Molecular Research, Inc., and Syneos Health Inc are the leading market players of the global Clinical trial outsourcing Market

down-arrow

New market players are advised to introduce cost effective and time-efficient models of testing and researching in order to facilitate fast drug approvals.

profile

Sakshi Bajaal

Business Consultant
Press Release

Clinical Trial Outsourcing Market to be Dominated by The Oncology Segment Through 2027

Aug, 2022

The growing prevalence of several lifestyle and rare case diseases along with the growing preference for personalized medicines and drugs is primarily driving the growth of global clinical trial outs